There are three classes of antiviral drugs approved for the treatment of influenza: the M2 ion channel inhibitors (amantadine, rimantadine), neuraminidase (NA) inhibitors (laninamivir, oseltamivir, peramivir, zanamivir), and the protease inhibitor (favipiravir); some...
CITATION STYLE
van der Vries, E., & Ison, M. G. (2017). Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects. In Antimicrobial Drug Resistance (pp. 1165–1183). Springer International Publishing. https://doi.org/10.1007/978-3-319-47266-9_23
Mendeley helps you to discover research relevant for your work.